Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
- Sacco brings significant rare disease commercial leadership experience including product launch and global commercial strategy CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the appointment of Tracey…